真空勃起装置在耐火性勃起功能障碍中的有效性:系统性审查和元分析
Fuxun Zhang1, Zhirong Luo1, Qi Xue1
1Department of Urology, Tangdu Hospital, Fourth Military Medical University, Xi'an, Shaanxi, China.
International journal of impotence research
|June 20, 2025
概括
真空勃起装置 (VED) 有效地改善了耐性勃起功能障碍 (ED) 的男性的性交成功和满意度,即使其他治疗方法失败. 阴茎伤是最常见的副作用,特别是在脊髓损伤患者中.
科学领域:
- 泌尿器科 泌尿器科 泌尿器科 泌尿器科
- 安德罗学与人类学
- 性医学性医学性医学性医学
背景情况:
- 真空勃起装置 (VED) 是一种已批准的治疗勃起功能障碍 (ED) 的疗法.
- 在耐火性ED中VED疗效的证据是有限的,通常对PDE5抑制剂无反应.
- 耐火性ED需要有效的治疗选择来改善患者的治疗结果.
研究的目的:
- 进行一项元分析,评估VED在耐火性ED患者的疗效和安全性.
- 为了确定VED疗效和常见副作用的发病率的聚合效应大小.
- 通过子组和元回归分析,探索影响VED疗效和副作用概况的因素.
主要方法:
- 在PubMed,EMBASE和Cochrane图书馆进行了系统的文献搜索,以查询到2024年12月的临床试验.
- 分析了18项研究中的1065名患者的数据.
- 主要结局是疗效 (成功性交/满意度);次要结局是副作用发生率. 计算了聚合利率和95%的CI. 使用科克兰的Q和I2测试来评估异质性. 进行了敏感性,子组和元回归分析. 出版偏差是使用漏斗图和埃格尔测试来评估的.
主要成果:
- 在耐火性ED中,VED的综合疗效为80% (95%CI:0.76-0.84).
- 具体的小组疗效包括:混合病因 (82.9%),糖尿病 (73.0%),脊髓损伤 (71.8%),以及后激进前列腺切除 (84.5%).
- 阴茎伤是最常见的副作用 (24.3%的综合发病率),脊髓损伤患者 (31.4%) 的发病率更高. 转基因回归表明出版日期和患者年龄可能会影响结果. 没有发现显著的出版偏差.
结论:
- 视频电脑是有效的辅助疗法,可以提高性交成功率和耐性勃起障碍患者的患者满意度.
- 对于那些对PDE5抑制剂没有反应的患者来说,VED提供了一个可行的治疗选择.
- 建议进行进一步的大规模随机对照试验,采用标准化测量和更长的随访,以证实研究结果.
相关概念视频
Male Sexual Response: Erection & Ejaculation
5.2K
Sexual stimulation can take various forms, such as physical touch and visual or auditory cues. When this happens, the parasympathetic reflex in the sacral portion of the spinal cord is activated. This reflex stimulates the release of nitric oxide (NO), which then dilates the arterioles in the penis, increasing blood flow to the erectile tissues - the corpora cavernosa and corpus spongiosum.
The blood filling the erectile tissues compresses the veins, which helps to prevent blood from leaving...
The blood filling the erectile tissues compresses the veins, which helps to prevent blood from leaving...
5.2K
Treatment for Pulmonary Arterial Hypertension: Phosphodiesterase Inhibitors
256
Phosphodiesterase 5 (PDE5) inhibitors are potent enzymes that function to hydrolyze cyclic nucleotides to their corresponding 5' monophosphates. Their unique biochemical properties have been applied in treating Pulmonary Arterial Hypertension (PAH).
Among the PDE5 inhibitors, sildenafil (Revatio) stands out as a competitive and selective inhibitor. It operates by elevating cellular levels of cGMP and augmenting signaling through the cGMP-PKG pathway, promoting vasodilation. Upon oral...
Among the PDE5 inhibitors, sildenafil (Revatio) stands out as a competitive and selective inhibitor. It operates by elevating cellular levels of cGMP and augmenting signaling through the cGMP-PKG pathway, promoting vasodilation. Upon oral...
256
Urodynamic Studies: Uroflowmetry
670
Uroflowmetry is a non-invasive urodynamic test designed to measure various aspects of urination, including volume, flow rate, and the time to void. This test is crucial for diagnosing and assessing conditions such as bladder outlet obstruction, bladder dysfunction, incomplete bladder emptying, incontinence, and urinary tract blockages caused by benign prostatic hyperplasia (BPH) and urethral strictures.Pre-Test Instructions:Before a uroflowmetry test, patients are typically advised to drink...
670


